Home › NCT06121661
APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adult (≥18 yrs) Emergency Department (ED) patient * Triaged to the "Acute" area of the ED. (The "Acute" area is the designated area for ED patients with potential or established critical illness. Triage to Acute is a routine ED operation that is performed based on departmental guidelines and the professional judgement of an experienced triage nurse). * Clinical concern for acute injury (based on either an explicitly chief complaint of acute injury, or clinical team with documented concern for acute injury as a relevant part of patient presentation). Exclusion Criteria: * Prisoners * Patients known to be pregnant, based on patient report, physical exam, or bedside ultrasound * Patients wearing an "EFIC Opt-Out" bracelet * Any concern about the suitability of the software system for a specific patient by any clinician involved in the patient's ED care, or by the patient themselves (or by any LAR \[lawfully authorized representative\] of the patient).
About the study
This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows:
1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use); 2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits; 3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.
What is being tested
- APPRAISE Trauma Clinical Decision Support System (device)
Sponsor: Andrew Tomas Reisner · Participants: 20 · Started: Feb 21, 2023
Contact the study team
- Iain Kehoe · Phone: 6177262241
Official record on ClinicalTrials.gov — NCT06121661
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.